rel-(1R,3R)-3-Methoxycyclohexan-1-amine hydrochloride

Catalog No. :
ACQSZB617
CAS No. :
1067908-49-9
Molecular Formula :
C7H16ClNO
Molecular Weight :
165.66

IUPAC Name:(1R,3R)-3-methoxycyclohexan-1-amine hydrochloride

rel-(1R,3R)-3-Methoxycyclohexan-1-amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$294.00Login to see priceIn stockInquiry
250mg98%$470.00Login to see priceIn stockInquiry
500mg98%$784.00Login to see priceIn stockInquiry
1g98%$1174.00Login to see priceIn stockInquiry
5g98%$3522.00Login to see priceIn stockInquiry
10g98%$5870.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,3R)-3-Methoxycyclohexan-1-amine hydrochloride
IUPAC Name(1R,3R)-3-methoxycyclohexan-1-amine hydrochloride
MDL No.MFCD31707757
Molecular FormulaC7H16ClNO
Molecular Weight165.66
SMILESN[C@H]1C[C@H](OC)CCC1.[H]Cl
InChI KeyVUHNATIEYBXEGU-ZJLYAJKPSA-N
Synonymtrans-3-methoxycyclohexanamine;trans-3-Methoxy-cyclohexylamine hydrochloride;Cyclohexanamine, 3-methoxy-, hydrochloride (1:1), (1R,3R)-rel-;trans-3-methoxycyclohexanamine hydrochloride;(1r,3r)-3-methoxycyclohexan-1-amine hydrochloride
CAS No.1067908-49-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQSZB617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQSZB617 route product structure diagram
    ACQSZB6171067908-49-9 In Stock
Inquiry

2. ACQSZB617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQSZB617 route product structure diagram
    ACQSZB6171067908-49-9 In Stock
Inquiry

Comments (0)